These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23979366)

  • 1. Recombinant soluble thrombomodulin as an adjunctive treatment for sepsis and disseminated intravascular coagulation: relatively safe and possibly effective.
    Fink MP
    Crit Care Med; 2013 Sep; 41(9):2221-3. PubMed ID: 23979366
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation.
    Vincent JL; Ramesh MK; Ernest D; LaRosa SP; Pachl J; Aikawa N; Hoste E; Levy H; Hirman J; Levi M; Daga M; Kutsogiannis DJ; Crowther M; Bernard GR; Devriendt J; Puigserver JV; Blanzaco DU; Esmon CT; Parrillo JE; Guzzi L; Henderson SJ; Pothirat C; Mehta P; Fareed J; Talwar D; Tsuruta K; Gorelick KJ; Osawa Y; Kaul I
    Crit Care Med; 2013 Sep; 41(9):2069-79. PubMed ID: 23979365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of recombinant thrombomodulin in septic patients].
    Eguchi Y
    Rinsho Byori; 2011 Feb; Suppl 147():177-80. PubMed ID: 21761768
    [No Abstract]   [Full Text] [Related]  

  • 4. Recombinant Thrombomodulin Used to Successfully Treat Cronkhite-Canada Syndrome with Disseminated Intravascular Coagulation due to Sepsis in a Compromised Patient.
    Morino K; Honma Y; Kumei S; Watanabe T; Kume K; Yoshikawa I; Harada M
    Intern Med; 2018 Nov; 57(21):3079-3085. PubMed ID: 29877275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [How to use AT concentrate or recombinant thrombomodulin for the patients with sepsis analyzed by laboratory markers].
    Eguchi Y; Yoshida T; Okabe H
    Rinsho Byori; 2011 Feb; Suppl 147():213-5. PubMed ID: 21761775
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant soluble thrombomodulin: coagulation takes another chance to reduce sepsis mortality.
    Levi M
    J Thromb Haemost; 2015 Apr; 13(4):505-7. PubMed ID: 25650725
    [No Abstract]   [Full Text] [Related]  

  • 7. A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.
    Takazono T; Nakamura S; Imamura Y; Yoshioka S; Miyazaki T; Izumikawa K; Sawai T; Matsuo N; Yanagihara K; Suyama N; Kohno S
    J Infect Chemother; 2014 Aug; 20(8):484-8. PubMed ID: 24855912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombomodulin in disseminated intravascular coagulation and other critical conditions-a multi-faceted anticoagulant protein with therapeutic potential.
    Ito T; Thachil J; Asakura H; Levy JH; Iba T
    Crit Care; 2019 Aug; 23(1):280. PubMed ID: 31416465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation - A meta-analysis.
    Kato H; Hagihara M; Asai N; Umemura T; Hirai J; Mori N; Yamagishi Y; Iwamoto T; Mikamo H
    Thromb Res; 2023 Jun; 226():165-172. PubMed ID: 37182388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study.
    Hayakawa M; Yamakawa K; Saito S; Uchino S; Kudo D; Iizuka Y; Sanui M; Takimoto K; Mayumi T; Ono K;
    Thromb Haemost; 2016 Jun; 115(6):1157-66. PubMed ID: 26939575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adequate application of recombinant thrombomodulin for sepsis-associated disseminated intravascular coagulation.
    Iba T
    Crit Care; 2015 May; 19(1):233. PubMed ID: 26002185
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of recombinant human thrombomodulin and gabexate mesylate for treatment of disseminated intravascular coagulation (DIC) with sepsis following emergent gastrointestinal surgery: a retrospective study.
    Akahoshi T; Sugimori H; Kaku N; Tokuda K; Nagata T; Noda E; Morita M; Hashizume M; Maehara Y
    Eur J Trauma Emerg Surg; 2015 Oct; 41(5):531-8. PubMed ID: 26038004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of esophageal cancer with septic disseminated intravascular coagulation treated with recombinant human soluble thrombomodulin during chemoradiation therapy].
    Sasaki K; Okumura H; Uchikado Y; Minami K; Ijichi T; Owaki T; Ishigami S; Natsugoe S
    Gan To Kagaku Ryoho; 2013 Sep; 40(9):1213-5. PubMed ID: 24047782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcomes of Recombinant Human-soluble Thrombomodulin Treatment for Disseminated Intravascular Coagulation in Solid Tumors.
    Kashiwagi S; Asano Y; Takahashi K; Shibutani M; Amano R; Tomita S; Hirakawa K; Ohira M
    Anticancer Res; 2019 May; 39(5):2259-2264. PubMed ID: 31092417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of antithrombin and recombinant human thrombomodulin combination therapy in patients with severe sepsis and disseminated intravascular coagulation.
    Yasuda N; Goto K; Ohchi Y; Abe T; Koga H; Kitano T
    J Crit Care; 2016 Dec; 36():29-34. PubMed ID: 27546744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of recombinant human soluble thrombomodulin in severe postpartum hemorrhage with disseminated intravascular coagulation.
    Sugawara J; Suenaga K; Hoshiai T; Sato T; Nishigori H; Nagase S; Yaegashi N
    Clin Appl Thromb Hemost; 2013 Sep; 19(5):557-61. PubMed ID: 22496090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant thrombomodulin and activated protein C in the treatment of disseminated intravascular coagulation.
    Maruyama I
    Thromb Haemost; 1999 Aug; 82(2):718-21. PubMed ID: 10605773
    [No Abstract]   [Full Text] [Related]  

  • 18. Addition of recommendations for the use of recombinant human thrombomodulin to the "Expert consensus for the treatment of disseminated intravascular coagulation in Japan".
    Wada H; ; Okamoto K; Iba T; Kushimoto S; Kawasugi K; Gando S; Madoiwa S; Uchiyama T; Mayumi T; Seki Y
    Thromb Res; 2014 Oct; 134(4):924-5. PubMed ID: 25135793
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment of disseminated intravascular coagulation in a child with acute myelogenous leukaemia using recombinant thrombomodulin.
    Ogawa E; Yagasaki H; Kato M; Shichino H; Chin M; Mugishima H
    Br J Haematol; 2010 Jun; 149(6):911-2. PubMed ID: 20346017
    [No Abstract]   [Full Text] [Related]  

  • 20. ADAMTS-13 activity can predict the outcome of disseminated intravascular coagulation in hematologic malignancies treated with recombinant human soluble thrombomodulin.
    Ohshiro M; Kuroda J; Kobayashi Y; Akaogi T; Kawata E; Uoshima N; Kamitsuji Y; Kaneko H; Shimura K; Shimazaki C; Murakami S; Hatsuse M; Okano A; Kobayashi T; Uchiyama H; Matsumoto Y; Horiike S; Taniwaki M
    Am J Hematol; 2012 Jan; 87(1):116-9. PubMed ID: 21989545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.